Investigation of the Genetic and Environmental Determinants of MP Including Response to Supplementation
1 other identifier
interventional
56
1 country
1
Brief Summary
This study aims to investigate genetic and environmental determinants of macular pigment (MP) and assess the effects of lutein and zeaxanthin-rich supplements on macular pigment levels.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy
Started Mar 2011
Longer than P75 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2011
CompletedFirst Submitted
Initial submission to the registry
January 25, 2013
CompletedFirst Posted
Study publicly available on registry
January 29, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedAugust 14, 2019
August 1, 2019
2.2 years
January 25, 2013
August 12, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Macular Pigment Measurement
Macular Pigment Measurement using Heterochromatic Flicker Photometry
16 weeks
Secondary Outcomes (2)
Serum Lutein and Zeaxanthin
16 weeks
Macular Pigment (reflectometry)
16 weeks
Study Arms (2)
Vitamin Supplement
EXPERIMENTAL1 capsule of Nutrof Total made by Laboratories Thea for 16 weeks
Inert oil capsule
PLACEBO COMPARATOR1 capsule daily for 16 weeks
Interventions
Eligibility Criteria
You may qualify if:
- healthy volunteers,
- male or female,
- aged 18-50 years
You may not qualify if:
- evidence of eye disease,
- inability to give informed written consent,
- any other health problem which would interfere with ability to adhere to the study protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre for Public Health
Belfast, Antrim, BT126BA, United Kingdom
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr Ruth Hogg
Study Record Dates
First Submitted
January 25, 2013
First Posted
January 29, 2013
Study Start
March 1, 2011
Primary Completion
May 1, 2013
Study Completion
December 1, 2013
Last Updated
August 14, 2019
Record last verified: 2019-08